Salute e Benessere

Reporting of transactions made by persons discharging managerial…

Company announcement no. 27 - 237 June 2023 Reporting of transactions made by persons discharging managerial responsibilities, and persons closely associated with them, in NTG's shares In accordance with section 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation), NTG Nordic Transport Group A/S (“NTG”), CVR no. 12546106, hereby announces receipt of the following notification from persons discharging...
Nasdaq GlobeNewswire
07/06/2023

Reporting of transactions made by persons discharging managerial…

Company announcement no. 26 - 237 June 2023 Reporting of transactions made by persons discharging managerial responsibilities, and persons closely associated with them, in NTG's shares In accordance with section 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation), NTG Nordic Transport Group A/S (“NTG”), CVR no. 12546106, hereby announces receipt of the following notification from persons discharging...
Nasdaq GlobeNewswire
07/06/2023

Reporting of transactions made by persons discharging managerial…

Company announcement no. 25 - 237 June 2023 Reporting of transactions made by persons discharging managerial responsibilities, and persons closely associated with them, in NTG's shares In accordance with section 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation), NTG Nordic Transport Group A/S (“NTG”), CVR no. 12546106, hereby announces receipt of the following notification from persons discharging...
Nasdaq GlobeNewswire
07/06/2023

Amolyt Pharma to Host Hybrid Key Opinion Leader Event on Eneboparatide, a PTHR1…

The event will featureAliya Khan, M.D., FRCPC, FACP, FACE, FASBMR (McMaster University Medical Centre), who will discuss the unmet medical needs for patients living with hypoparathyroidism and present the full results of the Phase 2a trial of eneboparatide, a parathyroid hormone receptor 1 (PTHR1) agonist with a novel mechanism of action. Patty Keating, patient and Chairwoman of the HypoPARAthyroidism Association, will share her personal experience living with the disease and...
Nasdaq GlobeNewswire
07/06/2023

Helicobacter Pylori Diagnostics Market to Reach $926.8 Million, Globally, by…

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/3543 Download Sample Report-https://www.alliedmarketresearch.com/request-sample/3543 Prime Determinants of Growth: The global Helicobacter pylori diagnostics market is experiencing growth due to several factors, including the rise in prevalence of infectious diseases, an increase in demand for non-invasive diagnostic procedures, and the development of new and improved testing methods. However, the lack of...
PR Newswire
07/06/2023

Global Wound Irrigation Solution Market to Surpass USD 2.01 Bn by 2031 | Growth…

Download PDF Sample here: https://growthmarketreports.com/request-sample/5220 Download PDF Sample here: https://growthmarketreports.com/request-sample/5220 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include type, application, and competitor analysis. This report also includes a complete analysis of...
PR Newswire
07/06/2023

Digital Science boosts pharma industry support following OntoChem acquisition

To achieve this, Digital Science – a technology company serving stakeholders right across the research ecosystem – has fully acquired OntoChem GmbH, a company highly specialized in AI-based solutions for finding and extracting key information from internal and external data and text, especially published research. To achieve this, Digital Science – a technology company serving stakeholders right across the research ecosystem – has fully acquired OntoChem GmbH, a company highly...
PR Newswire
07/06/2023

Nexgen Packaging and Kidkanai Announce Sustainable Hanger Launch

Kidkanai offers a unique shopping experience to parents seeking responsibly sourced, preloved children's clothing and accessories. As in most retail spaces, the most common option for hanging clothing was to use plastic hangers. Plastic hangers contribute to environmental pollution as they are non-biodegradable and often end up in landfills. Finding hangers that matched Kidkanai's eco-friendly values posed a challenge for the store. Kidkanai offers a unique shopping experience to parents...
PR Newswire
07/06/2023

ACROBiosystems expands custom GMP-grade protein services to drive CGT…

With experience in developing over 5,000 recombinant protein products and 10+ years in protein development and manufacturing, ACROBiosystems' is a well-established enterprise in this field. Offering a wide expanse of growth factors for cell culture and different product grades (e.g., RUO, Premium, and GMP), ACROBiosystems' product catalog is designed to maintain a comprehensive list of reagents necessary throughout the drug development process, starting from discovery to commercialization…
PR Newswire
07/06/2023

D&A Pharma: New confirmation for sodium oxybate in the treatment of alcohol…

These new studies included 1,082 patients and were conducted by Julien Guiraud and a group of international experts under the supervision of renowned professors in the field of addiction treatment: These new studies included 1,082 patients and were conducted byJulien Guiraudand a group of international experts under the supervision of renowned professors in the field of addiction treatment: Mannheim Medical School, University ofHeidelberg (Germany) The thesis is based on...
PR Newswire
07/06/2023

Resitu Medical AB's Stefan Sowa Wins Two Business Worldwide Magazine CEO Awards

Breast cancer is the most common cancer among women worldwide, accounting for approximately a third of all cancers in women. Resitu's cutting edge medical device will enable diagnosis and treatment of patient in one step, eliminating the need for open surgery, improving the patient's experience and reducing healthcare costs. Breast cancer is the most common cancer among women worldwide, accounting for approximately a third of all cancers in women. Resitu's cutting edge medical device will...
PR Newswire
07/06/2023

Translumina bolsters its German presence with acquisition of Lamed GmbH

Lazaros Ayvatoglou, the founder of Lamed, is convinced to have chosen the right partner in Translumina for further development of its well-established platform. He said, "After the initial discussion, it was clear that both businesses enrich each other with manifold growth opportunities. I am happy to have found a partner that builds on the established foundation of Lamed for a successful future." Lazaros Ayvatoglou, the founder of Lamed, is convinced to have chosen the right partner…
PR Newswire
07/06/2023

New Study from Diversey shows that contact time and disinfectant formulation has…

The Diversey funded, peer reviewed Voorn et al. study, selected for its impact on the hygiene and disinfection industry and published in the Scientific Reports journal by Voorn et al. is part of Diversey's research into disinfection performance to study environmental surfaces and patient care equipment in healthcare facilities. Prior to this research, little was known about disinfectant efficacy against C. auris when wiping larger surfaces, such as would be found in healthcare facilities. The...
PR Newswire
07/06/2023

The HARMONY Alliance is set to become a research foundation

The HARMONY Alliance is a community with over 500 professionals, including 120 organizations from 19 European countries (hospitals, universities, medical associations, 9 big pharma companies, HTAs, tech enterprises and 9 European patient organizations). When HARMONY started in 2017, the hematology community was embarking on a journey towards embracing data sharing and recognizing the transformative power of big data. HARMONY set a crucial milestone when this endeavor was only starting. By laying…
PR Newswire
07/06/2023

Curasight A/S reports positive preclinical results with uTREAT® in aggressive…

"We are extremely encouraged by these results, which further affirm our commitment to advancing our theranostic platform, comprising uTRACE® and uTREAT®, for evaluation in patients with aggressive brain cancer. The urgent need to enhance therapeutic outcomes in this challenging disease drives our strategic pursuit," commented Ulrich Krasilnikoff, CEO of Curasight. "We are extremely encouraged by these results, which further affirm our commitment to advancing our theranostic…
PR Newswire
07/06/2023

Nexstim Receives an NBS 5+ System Order from a New US Customer

Press release, Helsinki, 7 June 2023 at 10 AM(EEST)Nexstim Receives an NBS 5+ System Order from a New US Customer Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces having received an NBS 5+ system order in the United States from a new customer in North Carolina.The NBS 5+ system combines the capabilities of Nexstim's NBS (Navigated Brain Stimulation) and NBT® (Navigated Brain Therapy) systems. The NBS system is FDA cleared for pre-surgical mapping of the…
Nasdaq GlobeNewswire
07/06/2023

Single Cell Discoveries receives first Illumina NovaSeq X Plus in the Benelux

Mauro Muraro, CEO of Single Cell Discoveries, expresses his enthusiasm for the delivery, stating, "We are thrilled to incorporate the Illumina NovaSeq X Plus sequencing system into our advanced infrastructure. This occasion underscores our dedication to providing our clients with the most innovative tools and services available in the single-cell field. With the NovaSeq X Plus system, we are now better equipped than ever to secure fast turnaround times and excellent quality throughout the…
PR Newswire
07/06/2023

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP…

Founded in 2001 by Riccardo Ballerini, Pharma D&S Group grew in 2003 with the arrival of Lino Fabrizi as partner. It strengthened its service offering on Regulatory Affairs, Product Quality and Process Compliance, Pharmacovigilance and Clinical Operations activities. In 2004, the Group launched Pharma Education Center (PEC), a training provider for the Life Sciences sector. In 2005, the two partners were joined by Marco Conti who founded C&P Engineering a consulting entity providing…
PR Newswire
07/06/2023

XNK Therapeutics appoints Hugo Petit as Chief Financial Officer

Hugo Petit has held senior positions within finance and business development since 2005, including CFO at MedCap and OxThera. Before joining XNK Therapeutics, he was CFO at Renewcell. Hugo has also worked as a management consultant at McKinsey & Company. Hugo holds an MBA in economics and executive management from Uppsala University, Sweden. Hugo Petithas held senior positions within finance and business development since 2005, including CFO at MedCap and OxThera. Before joining XNK...
PR Newswire
07/06/2023

InfiRay® Debuts at WIN EURASIA 2023

Besides the M/C series handheld thermal imagers used in equipment inspection and hardware circuit design etc., some newest devices were shown in Turkey for the first time, such as S1280 which won the 2023 German Red Dot Design Award; the ATU series online high-temperature infrared thermal imager that can be widely used in metallurgy and chemical engineering. Moreover, InfiRay also brought gas thermal imaging cameras, which can not only detect VOCs gases such as CH4, but also SF6 required for…
PR Newswire
07/06/2023

VALNEVA - Declaration of shares and voting rights: May 31, 2023

VALNEVADeclaration of shares and voting rights May 31 , 2023__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment BDeclaration date: June 7, 2023 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the...
Nasdaq GlobeNewswire
07/06/2023

DBV Technologies to Participate in Upcoming Investor Conference

DBV Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its participation in the Goldman Sachs 44 thAnnual Global Healthcare Conference taking place on June 12 th– 15 thin Dana Point, CA. Daniel Tassé, Chief Executive Officer, will engage in a Fireside Chat session on Wednesday, June 14 that 10:00am PST (1:00pm EST), as well...
Nasdaq GlobeNewswire
06/06/2023

Canada becomes first country to require a health warning directly on every…

It is expected that many countries will follow Canada's example and adopt this measure, just as there are now more than 130 countries/territories that have required picture warnings for cigarette packages, following the Canadian precedent implemented in 2001. In many countries cigarettes are often sold individually without packaging – in these countries, warnings directly on cigarettes have the potential for even greater impact. It is expected that many countries will followCanada'sexample...
PR Newswire
06/06/2023

Unlocking Lucrative Opportunities: Sexual Wellness Market Projected to Reach $54…

The Emergence of a New Sexual Culture Propels Growth in the Sexual Wellness Market The Emergence of a New Sexual Culture Propels Growth in the Sexual Wellness Market The ongoing creation of a new sexual culture devoid of the stigma attached to the concept of sex is witnessing the exploration of sexual fantasies, driving the change in attitudes, and linking sexual wellness to a healthy lifestyle. These products have garnered extensive media exposure and a supportive environment encouraging...
PR Newswire
06/06/2023
Altri  Comunicati